CaamTech Raises $22M With A Broad Portfolio Of Novel Psychedelic Drugs
CaaMTech, a drug discovery company in the psychedelics space, has closed a $22 million Series A financing round.
The company is focused on building a patent library of analytically pure, well-characterized psychedelic drugs for psychiatry and other health purposes.
